BLLN

BillionToOne, Inc.
$110.67previous close on: 9/17/2026

Company Information

Company Name
BillionToOne, Inc.
CIK
CIK0002070849
Category
Non-accelerated filer<br>Emerging growth company
Ticker: Exchange
BLLN: Nasdaq
Fiscal Year End
December 31
Owner Organization
08 Industrial Applications and Services
SIC
8071
SIC Description
Services-Medical Laboratories
Ticker
BLLN

SEC filing data through

Insider Sentiment

Last purchase
2025-11-07
Last sale
2026-06-24
Shares purchased (TTM)
52,966
Shares sold (TTM)
75,664
Buy ratio (TTM)41.2%

Institutional Sentiment

As of
2026-03-31
Institutional shares owned
10,274,855
Shares outstanding
45,932,719
Ownership
22.37%

Earnings Market Reaction

Filing date
2026-08-05
Price on filing date
1-month reaction
-37.83%
3-month reaction
Pending
Drift continued3/3 (100%)
Faded / reversed0/3 (0%)

Balance Sheet

Values in millions ($)
Line item2026-06-302026-03-312025-12-312025-09-30Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnTrend
Assets Current
Cash And Cash Equivalents At Carrying Value549537496195
Accounts Receivable Net Current75614235
Inventory Net21191817
Prepaid Expense And Other Assets Current7655
Assets Current651624561252
Property Plant And Equipment Net25222019
Operating Lease Right Of Use Asset48494748
Other Assets Noncurrent6559
Assets730701633328
Liabilities Current
Accounts Payable Current12978
Other Accounts Payable And Accrued Liabilities13978
Accrued Sales Commission Current4443
Accrued Employee Benefits Current18181314
Derivative Liabilities Current099-
Contract With Customer Liability Current2323
Operating Lease Liability Current6655
Finance Lease Liability Current0011
Liabilities Current56574841
Operating Lease Liability Noncurrent46484647
Finance Lease Liability Noncurrent0000
Contract With Customer Liability Noncurrent001-
Temporary Equity Carrying Amount Attributable To Parent-00419
Long Term Debt91905755
Other Liabilities Noncurrent--04
Liabilities193195153148
Equity
Common Stock Value---0
Additional Paid In Capital78776475741
Accumulated Other Comprehensive Income Loss Net Of Tax-2-2-2-
Retained Earnings Accumulated Deficit-249-257-275-281
Stockholders Equity537506480-240
Liabilities And Stockholders Equity730701633328
Common Stock--0-
Temporary Equity Shares Outstanding-0029
Temporary Equity Liquidation Preference--0422
Common Stock Par Or Stated Value Per Share---0.00
Common Stock Shares Authorized---51
Common Stock Shares Issued---11
Shares Outstanding---11
Common Class A1410-
Common Class B-050-
Temporary Equity Par Or Stated Value Per Share--0.000.00
Temporary Equity Shares Authorized--5030
Temporary Equity Shares Issued--029

Select a line item above to chart it.

Recent filings

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial

BillionToOne, Inc. (BLLN) — SEC Financial Statements & Analysis

BillionToOne, Inc. (BLLN) is a services-medical laboratories company, incorporated in DE. BillionToOne, Inc. trades on Nasdaq as: BLLN. BillionToOne, Inc. (BLLN)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-05. Based on that filing, BillionToOne, Inc. carries a market cap of $5.57B, a P/E ratio of 166.30x, a P/B ratio of 10.37x, a P/S ratio of 10.65x, an enterprise value of $5.11B, and an EV/EBITDA multiple of 102.53x. On profitability, it posts a gross margin of 69.73%, an operating margin of 7.53%, a net margin of 6.40%, a Return on Equity (ROE) of 6.24%, a Return on Assets (ROA) of 4.59%, and a Return on Invested Capital (ROIC) of 43.50%. Per share, it reports EPS of $0.72, diluted EPS of $0.61, free cash flow per share of $0.68, and a dividend per share of $0.00. On the balance sheet, it maintains a current ratio of 11.69x, a quick ratio of 11.19x, working capital of $595.65M, a debt-to-equity ratio of 0.36x, a debt ratio of 0.26, an interest coverage ratio of 348.32x, free cash flow of $31.76M (TTM), and net debt of $-457.60M. Figures sourced from SEC EDGAR.

Market Cap
$5.57B
P/E TTM
166.30x
EPS TTM
$0.72
P/B TTM
10.37x
ROE TTM
6.24%
ROA TTM
4.59%
Debt To Equity
0.36x
Free Cash Flow TTM
$31.76M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is BillionToOne, Inc. in?

BillionToOne, Inc. (BLLN) operates in the Services-Medical Laboratories industry.

What exchange does BLLN trade on?

BillionToOne, Inc. (BLLN) trades on the Nasdaq.

Where is BillionToOne, Inc. incorporated?

BillionToOne, Inc. is incorporated in DE.

When was BillionToOne, Inc. (BLLN)'s most recent SEC filing?

BillionToOne, Inc. (BLLN)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-05.

What is BLLN's market cap?

BillionToOne, Inc. (BLLN) has a market capitalization of $5.57B as of 2026-06-30.

What is BLLN's P/E ratio?

BillionToOne, Inc. (BLLN)'s trailing twelve month P/E ratio is 166.30x as of 2026-06-30.

What is BLLN's EPS (earnings per share)?

BillionToOne, Inc. (BLLN)'s trailing twelve month EPS is $0.72 as of 2026-06-30.

What is BLLN's ROE (return on equity)?

BillionToOne, Inc. (BLLN)'s trailing twelve month Return on Equity (ROE) is 6.24% as of 2026-06-30.

What is BLLN's ROA (return on assets)?

BillionToOne, Inc. (BLLN)'s trailing twelve month Return on Assets (ROA) is 4.59% as of 2026-06-30.

What is BLLN's ROIC (return on invested capital)?

BillionToOne, Inc. (BLLN)'s trailing twelve month Return on Invested Capital (ROIC) is 43.50% as of 2026-06-30.

What is BLLN's EV/EBITDA?

BillionToOne, Inc. (BLLN)'s trailing twelve month EV/EBITDA is 102.53x as of 2026-06-30.

Wall Street's data.
Main Street's price.